Last year the annual meeting was fairly late (2/2/2019) despite an agenda that was all routine business; re-elect 2 directors, approve auditor, options for independent Directors.
The first step to being treated like a real company is to act like one.
Looks like they are slow to get their website updated with the executive info. It shows up better here: https://www.marketwatch.com/investing/stock/NWBO/insiders?pid=12927529 Officers and Executives Ms. Linda F. Powers Chairman, President & Chief Executive Officer Ms. Jean M. Davis CFO, Chief Accounting & Information Officer Dr. Kevin T. Duffy VP-Medical Affairs & External Collaborations Dr. Marnix L. Bosch Chief Technical Officer Dr. Alton L. Boynton Secretary, Director & Chief Scientific Officer Mr. Leslie J. Goldman Senior Vice President-Business Development Dr. Anthony E. Maida Senior Vice President-Clinical Research Mr. David Innes Vice President-Investor Relations Dr. Navid Malik Independent Director Mr. Jerry J. Jasinowski Independent Director Mr. J. Cofer Black Independent Director